Southport Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,139
Closed -$315K 283
2021
Q4
$315K Buy
+1,139
New +$289K 0.06% 245
2021
Q3
Sell
-1,098
Closed -$252K 272
2021
Q2
$252K Sell
1,098
-6
-0.5% -$1.21K 0.06% 260
2021
Q1
$206K Buy
+1,104
New +$216K 0.05% 282
2018
Q4
Sell
-528
Closed -$57K 343
2018
Q3
$57K Buy
+528
New +$52.8K 0.02% 241
2016
Q3
Sell
-1,175
Closed -$93K 328
2016
Q2
$93K Buy
+1,175
New +$88.5K 0.05% 231

Other funds holding LLY

Southport Capital Management's LLY Position: Q1 2022 in Review

Southport Capital Management sold out of Eli Lilly (LLY) in Q1 2022, closing a stake of 1,139 shares — an estimated $315K sold.

Southport Capital Management first reported a position in LLY in Q2 2016 and held it in 5 quarters. The position peaked at $315K in Q4 2021. 2,346 funds tracked by Wall St. Rank hold LLY as of Q1 2022.

  • Southport Capital Management reported no remaining Eli Lilly position as of Q1 2022 after selling out during the quarter.
  • Southport Capital Management sold 1,139 Eli Lilly shares in Q1 2022, an estimated $315K.
  • Southport Capital Management first reported a position in Eli Lilly in Q2 2016 and held it in 5 quarters.
  • Southport Capital Management's Eli Lilly position peaked at $315K in Q4 2021.
  • 2,346 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.

Based on Southport Capital Management's 13F filing for Q1 2022, filed 25 Apr 2022.